Naurex's Series B Round

Naurex raised a round of funding on December 17, 2012.

Naurex is a biopharmaceutical company developing novel modulators of the NMDA receptor to treat challenging diseases of the central nervous system (CNS). The company's first-generation compound, GLYX-…

Articles about Naurex's Series B Round: